We are live on !
Find out more
Diversified Trust Portfolio holdings
AUM
$6.24B
Turnover
21.75%
1-Year Est. Return
28.78%
This Fund
S&P 500
This Quarter Est. Return
+14.8%
1 Year Est. Return
+28.78%
3 Year Est. Return
+81.47%
5 Year Est. Return
+98.81%
10 Year Est. Return
+246.51%
AUM
$6.24B
AUM Growth
+$848M
(+16%)
Cap. Flow
+$123M
Cap. Flow % of AUM
Cap. Flow %
1.97%
Top 10 Holdings %
Top 10 Hldgs %
45.03%
Holding
1,214
New
165
Increased
486
Reduced
333
Closed
99
Avg Time Held
3.1
years
Top 10 Avg Time Held
6.4
years
Top 20 Avg Time Held
5.9
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Martin Marietta Materials
MLM
|
+$15.4M |
| 2 |
Vanguard FTSE All-World ex-US ETF
VEU
|
+$10.5M |
| 3 |
Coca-Cola
KO
|
+$7.77M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$7.4M |
| 5 |
Linde
LIN
|
+$6.64M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procter & Gamble
PG
|
+$8.79M |
| 2 |
Vanguard Morningstar Total Stock Market ETF
VTI
|
+$8.54M |
| 3 |
IQVIA
IQV
|
+$8.33M |
| 4 |
Coca-Cola Europacific Partners
CCEP
|
+$6.96M |
| 5 |
Apple
AAPL
|
+$6.43M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 52.31% |
| 2 | Technology | 14.45% |
| 3 | Consumer Staples | 6.96% |
| 4 | Financials | 6.19% |
| 5 | Healthcare | 5.09% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
926
Janux Therapeutics
JANX
$1.02B
| $259K | ﹤0.01% |
+16,841
| New | +$244K |
2026 Q2
0 quarters
|
|
927
Insight Enterprises
NSIT
$5.19B
| $258K | ﹤0.01% |
+2,119
| New | +$193K |
2026 Q2
0 quarters
|
|
928
iShares MSCI Emerging Markets Asia ETF
EEMA
$798M
| $258K | ﹤0.01% |
2,204
| – | – |
2017 Q1
37 quarters
|
|
929
British American Tobacco
BTI
$128B
| $256K | ﹤0.01% |
4,153
-2,616
| -39% | -$158K |
2026 Q1
1 quarter
|
|
930
Banco Santander
SAN
$186B
| $256K | ﹤0.01% |
18,578
+1,124
| +6% | +$13.9K |
2025 Q2
4 quarters
|
|
931
PTC
PTC
$21.1B
| $256K | ﹤0.01% |
2,253
-43
| -2% | -$5.81K |
2023 Q1
13 quarters
|
|
932
Dimensional International High Profitability ETF
DIHP
$6.47B
| $256K | ﹤0.01% |
7,500
| – | – |
2025 Q1
5 quarters
|
|
933
Aveanna Healthcare
AVAH
$2.92B
| $256K | ﹤0.01% |
29,855
+7,562
| +34% | +$53.3K |
2025 Q2
4 quarters
|
|
934
MP Materials
MP
$6.82B
| $256K | ﹤0.01% |
4,563
+58
| +1% | +$3.53K |
2025 Q3
3 quarters
|
|
935
iShares MSCI KLD 400 Social ETF
DSI
$5.44B
| $255K | ﹤0.01% |
1,792
| – | – |
2025 Q2
4 quarters
|
|
936
Xeris Biopharma Holdings
XERS
$1.86B
| $254K | ﹤0.01% |
32,062
| – | – |
2021 Q4
18 quarters
|
|
937
Marcus Corp
MCS
$862M
| $254K | ﹤0.01% |
+10,814
| New | +$213K |
2026 Q2
0 quarters
|
|
938
Constellation Brands
STZ
$23.5B
| $254K | ﹤0.01% |
1,823
+38
| +2% | +$5.65K |
2025 Q4
2 quarters
|
|
939
iShares ESG MSCI USA Leaders ETF
SUSL
$1.21B
| $252K | ﹤0.01% |
1,901
| – | – |
2021 Q1
21 quarters
|
|
940
Huazhu Hotels Group
HTHT
$14.6B
| $252K | ﹤0.01% |
6,034
-27,268
| -82% | -$1.3M |
2026 Q1
1 quarter
|
|
941
Astera Labs
ALAB
$44.6B
| $251K | ﹤0.01% |
520
-3,849
| -88% | -$1.02M |
2025 Q3
3 quarters
|
|
942
Biogen
BIIB
$37B
| $249K | ﹤0.01% |
1,154
-112
| -9% | -$21.4K |
2026 Q1
1 quarter
|
|
943
Arthur J. Gallagher & Co
AJG
$68.7B
| $249K | ﹤0.01% |
+1,086
| New | +$231K |
2026 Q2
0 quarters
|
|
944
Principal Financial Group
PFG
$23.2B
| $248K | ﹤0.01% |
+2,302
| New | +$234K |
2026 Q2
0 quarters
|
|
945
DT Midstream
DTM
$12.6B
| $248K | ﹤0.01% |
1,689
+111
| +7% | +$15.7K |
2025 Q4
2 quarters
|
|
946
CME Group
CME
$110B
| $246K | ﹤0.01% |
1,113
-702
| -39% | -$194K |
2025 Q1
5 quarters
|
|
947
DELISTED
SIEMENS AKTIENGESELLSCHAFT ADS
SI
| $242K | ﹤0.01% |
+1,508
| New | +$242K |
2026 Q2
0 quarters
|
|
948
Revvity
RVTY
$17.7B
| $242K | ﹤0.01% |
+2,175
| New | +$209K |
2026 Q2
0 quarters
|
|
949
Aclaris Therapeutics
ACRS
$552M
| $241K | ﹤0.01% |
45,523
+16,068
| +55% | +$71.7K |
2026 Q1
1 quarter
|
|
950
SSR Mining
SSRM
$5.79B
| $240K | ﹤0.01% |
8,480
-57
| -0.7% | -$1.74K |
2025 Q3
3 quarters
|
|
Similar funds
EQF
Diversified Trust's Q2 2026 Portfolio in Review
As of Q2 2026, Diversified Trust held 1,214 positions worth $6.24B, up 16% from $5.39B the previous quarter. Its ten largest holdings account for 45% of the portfolio.
Diversified Trust's Q2 2026 filing shows 165 new, 486 increased, 333 reduced and 99 closed positions. Its largest new stake was Installed Building Products: 11,576 shares worth $2.66M. The largest sale was Procter & Gamble, an estimated $8.79M.
By sector, the portfolio is most concentrated in Miscellaneous at 52% of assets, up from 51% a quarter earlier, followed by Technology and Consumer Staples.
- Diversified Trust's largest Q2 2026 buy was Installed Building Products: 11,576 shares worth $2.66M.
- Diversified Trust added most to Martin Marietta Materials in Q2 2026, an estimated $15.4M increase.
- Diversified Trust's biggest Q2 2026 reduction was Procter & Gamble, cutting an estimated $8.79M.
- Diversified Trust fully exited IQVIA in Q2 2026, selling an estimated $8.33M.
- Diversified Trust's ten largest holdings make up 45% of its $6.24B portfolio in Q2 2026.
- Diversified Trust opened 165 new positions and closed 99 in Q2 2026.
- Diversified Trust's portfolio value rose 16% quarter-over-quarter to $6.24B.
Based on Diversified Trust's 13F filing for Q2 2026, filed 17 Jul 2026.